Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Andreassen, A.
Right arrow Articles by Alexander, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreassen, A.
Right arrow Articles by Alexander, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis, Vol. 16, No. 4, 309-315, July 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press

Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele

Åshild Andreassen, Rose Vikse, Inger-Lise Steffensen, Jan Erik Paulsen and Jan Alexander1,

Department of Environmental Medicine, National Institute of Public Health, PO Box 4404 Nydalen, N-0403, Oslo, Norway

C57BL/6J-Min/+ (multiple intestinal neoplasia) is a murine model for familial adenomatous polyposis (FAP), where the mice are heterozygous for a nonsense ApcMin (adenomatous polyposis coli) mutation, and therefore develop numerous spontaneous adenomas in the small intestine and colon. Neonatal exposure of Min/+ mice to the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) (eight subcutaneous injections of 25 or 50 mg/kg PhIP to pups or 50 mg/kg PhIP to lactating dams) markedly increased (2–9-fold) the number of intestinal tumours, especially in the small intestine. We examined whether the Apc gene was affected in small intestinal and colonic tumours induced by PhIP. In spontaneous tumours formed in these mice, the main mechanism for tumour induction is loss of the wild-type Apc+ allele, i.e. loss of heterozygosity (LOH). Also in the PhIP-induced tumours, this is a major mechanism, since large fractions of PhIP-induced tumours had LOH in Apc. However, mechanisms other than LOH must also prevail, since a lower frequency of LOH was found in the small intestinal tumours from male mice exposed to PhIP either via breast milk (65%) or by direct injection (68%), compared with the untreated controls (92%). Tumours that had retained the wild-type Apc+ allele were further analysed for presence of truncated Apc proteins with in vitro synthesized protein (IVSP) assay. Truncated Apc proteins, indicating truncation mutations in exon 15 of the Apc gene, were detected in 20% (8 of 40) of the tumours not showing LOH from the small intestine after PhIP exposure, all in segment 2 (codons 686–1217). Seventeen percent (2 of 12) of the colonic tumours had a truncated Apc protein in segment 3 (codons 1099–1693). Importantly, no truncated proteins were detected in tumours from unexposed mice with apparently retained wild-type Apc+ allele. These results show that PhIP induces intestinal tumours in the Min/+ mice both by causing LOH and truncation mutations in the wild-type Apc+ allele.

Å.Andreassen and R.Vikse contributed equally to this work

1 To whom correspondence should be addressed. Email: jan.alexander{at}folkehelsa.no


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Fang, R. J. Edwards, M. Bartlet-Jones, G. W. Taylor, S. Murray, and A. R. Boobis
Urinary N2-(2'-deoxyguanosin-8-yl)PhIP as a biomarker for PhIP exposure
Carcinogenesis, June 1, 2004; 25(6): 1053 - 1062.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Mochida, K.-i. Taguchi, S. Taniguchi, M. Tsuneyoshi, H. Kuwano, T. Tsuzuki, M. Kuwano, and M. Wada
The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in ApcMin/+ mice
Carcinogenesis, July 1, 2003; 24(7): 1219 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. E. Corpet and F. Pierre
Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Husoy, V. Cruciani, H. K. Knutsen, S.-O. Mikalsen, H. B. Olstorn, and J. Alexander
Cells heterozygous for the ApcMin mutation have decreased gap junctional intercellular communication and connexin43 level, and reduced microtubule polymerization
Carcinogenesis, April 1, 2003; 24(4): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I.-L. Steffensen, J. E. Paulsen, and J. Alexander
The food mutagen 2-amino-9H-pyrido[2,3-b]indole (A{alpha}C) but not its methylated form (MeA{alpha}C) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice
Carcinogenesis, August 1, 2002; 23(8): 1373 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander
Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts
Cancer Res., December 1, 2001; 61(24): 8689 - 8696.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.